Adynovate is an innovative extended half-life ... After the Shire deal, which closes on January 8, Takeda will have a stronger pipeline and be counted among the top 10 drugmakers by sales globally.

Takeda Pharmaceutical ... The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba ...

Japanese drug-making giant, Takeda Pharmaceutical Co., is ... the research-based firm plans to launch five new products in Saudi Arabia: Adynovate for the blood-clotting disorder hemophilia ...

Our performance and outlook speak to the strength of our Growth & Launch Products, our innovative pipeline and the resilience of our organization as a whole. “Takeda is now at an inflection ...

Core operating profit margin improved to 28.5%, reflecting strong product performance, slower-than-expected VYVANSE generic ...